CATABASIS PHARMACEUTICALS INC Business Finance Contracts & Agreements
30 Contracts & Agreements
- Credit Agreements (1 contract)
- Investor Rights Agreements (2)
- Registration Rights Agreements (2)
- Stock Agreements (5)
- Underwriting Agreements (9)
- Warrant Agreements (11)
- Underwriting Agreement, dated January 30, 2024, by and among Astria Therapeutics, Inc., Jefferies LLC and Evercore Group L.L.C (Filed With SEC on January 31, 2024)
- Form of Common Stock Warrant (Filed With SEC on October 12, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on October 12, 2023)
- Underwriting Agreement, dated October 11, 2023, by and among Astria Therapeutics, Inc., Jefferies LLC and Evercore Group L.L.C (Filed With SEC on October 12, 2023)
- Underwriting Agreement, dated December 15, 2022, by and among Astria Therapeutics, Inc., Jefferies LLC and Evercore Group L.L.C (Filed With SEC on December 15, 2022)
- 2015 Employee Stock Purchase Plan (Filed With SEC on May 12, 2022)
- Warrant to Purchase Shares of Common Stock issued on January 28, 2021 to Viridian LLC (Filed With SEC on March 11, 2021)
- Warrant to Purchase Shares of Series X Preferred Stock issued on January 28, 2021 to Viridian LLC (Filed With SEC on March 11, 2021)
- Registration Rights Agreement, dated as of January 28, 2021, by and among the Registrant and each purchaser identified therein (Filed With SEC on March 11, 2021)
- Form of Registration Rights Agreement, by and among Catabasis Pharmaceuticals, Inc. and certain purchasers named therein (Filed With SEC on January 29, 2021)
- Stock Purchase Agreement, dated as of January 28, 2021, by and among Catabasis Pharmaceuticals, Inc. and each purchaser identified on Annex A thereto (Filed With SEC on January 29, 2021)
- Underwriting Agreement, dated January 30, 2020, by and between the Company and Oppenheimer & Co. Inc (Filed With SEC on January 30, 2020)
- Form of Warrant (Filed With SEC on February 6, 2019)
- Underwriting Agreement, dated February 6, 2019, by and between the Company and Oppenheimer & Co. Inc (Filed With SEC on February 6, 2019)
- Form of Common Warrant (Filed With SEC on June 20, 2018)
- Underwriting Agreement, dated June 19, 2018, by and between the Company and the Underwriter (Filed With SEC on June 20, 2018)
- Form of Warrant (Filed With SEC on June 15, 2018)
- Form of Warrant (Filed With SEC on June 12, 2018)
- Form of Pre-Funded Warrant (Filed With SEC on June 12, 2018)
- Form of Underwriting Agreement (Filed With SEC on June 12, 2018)
- Catabasis Pharmaceuticals, Inc. 2,500,000 Shares Common Stock ($0.001 par value per share) Underwriting Agreement (Filed With SEC on September 23, 2016)
- CATABASIS PHARMACEUTICALS, INC. $10,000,000 COMMON STOCK SALES AGREEMENT (Filed With SEC on August 11, 2016)
- SECOND AMENDMENT TO CREDIT AND SECURITY AGREEMENT (Filed With SEC on March 15, 2016)
- CATABASIS PHARMACEUTICALS, INC. SECOND AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (Filed With SEC on June 11, 2015)
- Catabasis Pharmaceuticals, Inc. Shares Common Stock ($0.001 par value per share) Underwriting Agreement (Filed With SEC on June 11, 2015)
- CATABASIS PHARMACEUTICALS, INC. 2015 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on June 3, 2015)
- CATABASIS PHARMACEUTICALS, INC. NONSTATUTORY STOCK OPTION AGREEMENT (Filed With SEC on June 3, 2015)
- WARRANT TO PURCHASE STOCK (Filed With SEC on May 13, 2015)
- WARRANT TO PURCHASE STOCK (Filed With SEC on May 13, 2015)
- CATABASIS PHARMACEUTICALS, INC. SECOND AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (Filed With SEC on May 13, 2015)
